Page last updated: 2024-08-26

artenimol and cytochrome c-t

artenimol has been researched along with cytochrome c-t in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's7 (87.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, T; Li, M; Wang, H; Zhang, R1
Budhraja, A; Chen, D; Chen, J; Cheng, S; Gao, N; Huang, C; Liu, EH; Shi, X; Yang, Z; Zhang, Z1
Chen, GG; Lai, PB; Yun, J; Zhang, CZ; Zhang, H1
Cao, Y; Chen, GG; Lai, PB; Liu, L; Pan, Y; Yun, J; Zhang, CZ1
Lee, J; Wu, X; Xu, F; Zhang, G; Zhang, X; Zhou, J1
Gao, W; Gu, H; Liu, J; Mao, H; Qu, X; Shao, Q; Song, B; Sun, J1
Lee, J; Shen, P; Wu, X; Zhang, G; Zhang, X1
Li, Y; Li, YW; Lv, SJ; Xu, N; Zhang, H; Zhang, W; Zhu, WH1

Other Studies

8 other study(ies) available for artenimol and cytochrome c-t

ArticleYear
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy.
    Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:7

    Topics: Apoptosis; Artemisinins; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Drug Screening Assays, Antitumor; Female; Humans; Membrane Potential, Mitochondrial; Mitochondrial Membranes; Models, Biological; Ovarian Neoplasms

2009
Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo.
    Apoptosis : an international journal on programmed cell death, 2011, Volume: 16, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Caspases; Cytochromes c; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Leukemia; MAP Kinase Kinase Kinases; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; U937 Cells; Xenograft Model Antitumor Assays

2011
Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo.
    Biochemical pharmacology, 2012, May-01, Volume: 83, Issue:9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; bcl-2 Homologous Antagonist-Killer Protein; Carcinoma, Hepatocellular; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cytochromes c; Drug Screening Assays, Antitumor; Genes, p53; Humans; Liver Neoplasms; Mice; Mitochondrial Membranes; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays

2012
Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Animals; Apoptosis; Artemisinins; Cell Line, Tumor; Cytochromes c; Drug Synergism; Enzyme Activation; Flow Cytometry; Histone Deacetylase Inhibitors; In Situ Nick-End Labeling; Liver Neoplasms; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Phosphorylation

2012
Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation.
    Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:12

    Topics: Artemisinins; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Down-Regulation; Fusion Proteins, bcr-abl; Growth Inhibitors; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; NF-kappa B; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger

2012
Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro.
    International journal of molecular medicine, 2013, Volume: 31, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Artemisinins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Breast Neoplasms; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Dose-Response Relationship, Drug; Female; Humans; Membrane Proteins; Microbial Sensitivity Tests; Mitochondria; Proto-Oncogene Proteins

2013
Dihydroartemisinin inhibits the Bcr/Abl oncogene at the mRNA level in chronic myeloid leukemia sensitive or resistant to imatinib.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2013, Volume: 67, Issue:2

    Topics: Antimalarials; Apoptosis; Artemisinins; Benzamides; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Genes, abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Mitochondria; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA, Messenger

2013
[Dihydroartemisinin inhibits proliferation of pancreatic cancer JF-305 cells by regulating expression of apoptosis related proteins and production of reactive oxygen species].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2017, Volume: 42, Issue:15

    Topics: Apoptosis; Artemisinins; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Proliferation; Cytochromes c; Humans; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species

2017